Abstract. We have been studying the pathogenesis of adjuvant arthritis in rats using a long-term cell line of T lymphocytes, the A2 line, which can induce polyarthritis and can also be used to vaccinate rats against adjuvant arthritis. Although line A2 was selected for its proliferative response to mycobacteria, it also responded to collagen type II. To elucidate its role of responsiveness to collagen type II and the relationship between arthritogenicity and vaccination, we cloned A2 and selected a subline A2b. We now report that subline A2b, which bore a marker of helper/delayed hypersensitivity T lymphocytes, was strongly arthritogenic, but could not vaccinate against arthritis. Moreover, A2b showed no response to collagen type II. Therefore, reactivity to collagen type II is not a requisite for arthritogenicity, and mediation of arthritis and vaccination can be distinct properties of different populations of T lymphocytes. (7) and in humans with rheumatoid arthritis (8), it has been suggested that collagen type II may be a critical self-antigen in autoimmune arthritis (7).
Introduction
Adjuvant arthritis (AA)' is a model of arthritis that presents with a pathological picture similar to that seen in rheumatoid arthritis (1, 2) . AA can be induced in susceptible strains of rats by a single intradermal injection of complete Freund's adjuvant (CFA) containing killed Mycobacterium tuberculosis (MT) in oil. Although AA is triggered by an immune response to mycobacterial antigens, the disease is transferable to naive recipient rats by inoculation of lymphoid cells obtained from affected Dr. Cohen is the incumbent of the Mauerberger Professorial Chair in Immunology.
rats (3) ; immune reactivity to joint antigens has also been detected (4) . This suggests that AA may be an autoimmune disease and that a self-antigen responsible for expression of AA could exist in the joints of normal rats. However, the identity of the critical self-antigen and its relationship to mycobacterial antigens remain obscure. It has been suggested that AA is not an autoimmune disease but results from an attack against MT antigens disseminated in the tissues (5) .
Autoimmune arthritis can be induced in rats by immunization to collagen type II, a collagen characteristic of joints (6) . Based on the finding of antibody or T lymphocyte responses to collagen type II in rats with AA (7) and in humans with rheumatoid arthritis (8) , it has been suggested that collagen type II may be a critical self-antigen in autoimmune arthritis (7) .
To investigate the pathogenesis of AA we developed lines of T lymphocytes from the draining lymph nodes of Lewis rats immunized to CFA (9) . Line A2, selected because of its proliferative response to whole MT, could induce polyarthritis upon intravenous injection into irradiated Lewis rats. Cells of line A2 could also be used to vaccinate rats against subsequent attempts to induce AA by active immunization to CFA. We observed that in addition to responding strongly to MT, line A2 proliferated in vitro to a relatively slight but significant degree to collagen type II. Hence it was conceivable that some MT antigens might cross-react with self-collagen type II and that induction of arthritis and/or vaccination against AA might be the property of line cells reactive to collagen type II (9) .
The present experiments were done to test this hypothesis. Accordingly, we prepared a cloned subline, A2b, that was found to be more strongly arthritogenic than the parent A2 line. How (1) .
Maintenance and cloning of line A2. Line A2 reactive to MT was isolated from rats immunized with CFA. On day 9 the draining lymph nodes were removed, and a T cell line reactive to MT was generated and maintained as we have described (9) . The MT, 10 Mg/ml; PPD, 25 Ag/ml; Con A, 2.5 Mg/ml; rat type I collagen, 50 Mg/ml; and rat type II collagen, 50 Mg/ml. After 24 h of incubation, each well was pulsed with I MCi of [3H]thymidine (specific activity 10 Ci/mmol; Nuclear Research, Negev, Israel) for 18 h. The cultures were then harvested on fiberglass filters and the incorporation of thymidine was measured using a liquid scintillation counter. The proliferative response was expressed as cpm (mean cpm of test cultures minus mean cpm of control cultures).
AA mediated by cell lines. Before being inoculated, line cells were restimulated with MT or Con A in the presence of accessory cells for 3 d. The lymphoblasts were collected, washed twice in PBS, and 2 X 107 cells in 1 ml ofPBS were injected into the tail vein of nonirradiated Lewis rats, or Lewis rats that had been irradiated 2 h earlier with 750 rad by a 'Co gamma ray source (GB 150 A, Atomic Energy of Canada Ltd., Commercial Projects, Ottawa, Ontario, Canada). The recipient rats were observed daily for clinical arthritis and were scored as above.
Results
Line A2 and subline A2b have the T helper phenotype. Fig. I shows an analysis of surface markers on subline A2b and on normal thymocytes. The Subline A2b is arthritogenic. Table II shows the results of inoculating Lewis rats intravenously with 2 X 107 cells of the parent A2 line or cloned subline A2b. As we reported earlier, arthritis was inducible only in recipient rats that had been irradiated before inoculation (9) . It can be seen that subline A2b was relatively more arthritogenic than the A2 parent line because it induced a more severe arthritis that began somewhat earlier and lasted longer. The more marked arthritogenicity of A2b was evident in each of four additional experiments. Thus, the ability to induce autoimmune arthritis was not correlated with reactivity to collagen type II expressed in the in vitro proliferative response. Arthritogenic potential is activated by Con A. As active AA is induced by immunization to MT, the target ofimmune attack might conceivably be bona fide MT antigens disseminated in the joints and not a cross-reactive self-antigen (5). According to this view, the transfer of AA by T lymphocyte lines activated by incubation with MT organisms could be explained by inadvertent transfer of minute amounts of MT antigens along with the line cells. We therefore undertook to induce arthritis with line cells that were not cultured with MT. We found previously that it was possible to activate the functional programs of line cells mediating autoimmune encephalomyelitis or autoimmune thyroiditis by incubation with Con A rather than specific antigen (12, 13). Table II shows that Con A also activated the arthritogenic potential of line A2 to the same extent as did incubation of the cells with MT. The last contact of the A2 line cells with MT was 4 wk before their activation, an interval marked by seven cell transfers, each involving a change of medium. Therefore, proximate contact with MT antigens and presumably their cotransfer with the line cells was not required for induction of arthritis.
Subline A2b does not induce resistance to AA. To test whether cloned subline A2b could be used to generate resistance to AA we inoculated rats, irradiated or not, with 2 X 107 cells of A2 or A2b and induced AA by active immunization with CFA 35 d later (Table 111 ). Control rats that had not received line cells developed AA with about the same incidence (80-90%) and degree of severity (arthritis score 8-9), whether or not they had been irradiated 35 d earlier. In contrast, rats inoculated with line A2 were markedly resistant to AA. Vaccination against AA was evident in rats that had not been irradiated and therefore had not suffered passive arthritis mediated by the line cells. Resistance was also acquired by the irradiated rats that had suffered arthritis. However, rats that had been inoculated with cloned subline A2b showed no resistance to AA, whether or not they had been irradiated and had suffered passive arthritis. (15) . Our finding that A2 line cells could induce arthritis subsequent to activation by Con A as well as by MT argues against an absolute requirement for MT in the cell inoculum. Therefore, the autoimmune hypothesis seems the more attractive because the presence of bacterial antigens in the joints of the recipient rats under such circumstances seems doubtful. We hope that the response of A2b to various antigenic fractions of MT will help identify the cross-reactive antigenic determinant and resolve the question.
The pathology of the arthritis induced by A2 or A2b will be reported in detail elsewhere. In general the lesion appeared similar to those seen in active AA or in rheumatoid arthritis and were marked by heavy mononuclear infiltration of the synovium, formation of pannus, and erosion of articular cartilage. The arthritogenic T lymphocyte lines bore the WI 3/25 marker of helper/delayed hypersensitivity T cells. It is unlikely that recipient rats irradiated by 750 rad could have contributed the B lymphocytes needed for formation of possibly arthritogenic antibodies (16) , which suggests that the line cells might induce arthritis by a delayed hypersensitivity reaction triggered by a cross-reactive self-antigen.
The mechanism of vaccination against AA induced by the A2 line cells remains to be clarified. The arthritogenic A2b subline, in contrast to the A2 line, failed to induce resistance even in rats in which it had caused arthritis. Thus, resistance was associated with the administration of a specific population of T lymphocytes and did not result from rats merely having suffered and spontaneously recovered from passive arthritis. In other words, the signal that induced protection was borne by the T lymphocyte line cells, and was not inherent in the arthritic joint. As A2 and A2b differ in the antigenic specificities they recognize, it is conceivable that resistance to AA was induced by immunity to the antiself receptors of the A2 line cells. This type ofantiidiotypic immunity is also compatible with the nature of the specific resistance induced by lines of T lymphocytes against autoimmune encephalomyelitis in rats and against autoimmune thyroiditis in mice (13, 17, 18) . If indeed vaccination is mediated by antireceptor or antiidiotypic immunity, it is conceivable that the cloned A2b subline failed to protect because its receptor, while sufficient to cause disease, did not immunize the recipient rats against the entire array of autoimmune idiotypes generated during active AA. In contrast, the A2 line might have been an effective vaccine because of its idiotypic heterogeneity.
The reactivity of line A2 to collagen type II was relatively modest but significant. One could speculate therefore that cells recognizing collagen type II might have some role in vaccination against active AA (9) . However, other interpretations are conceivable and these hypotheses must be tested with suitable antiidiotypic reagents and clones specific for collagen type II. In any event, the results clearly prove that disease and vaccination can be dissociated properties of autoimmune T lymphocytes.
